Global Gastrointestinal OTC Drugs Market Research Report 2018

Publisher Name :
Date: 13-Apr-2018
No. of pages: 118
Inquire Before Buying

This report studies the global Gastrointestinal OTC Drugs market status and forecast, categorizes the global Gastrointestinal OTC Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

In 2017, the global Gastrointestinal OTC Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report

- Bayer

- GlaxoSmithKline

- Johnson & Johnson

- Pfizer

- Perrigo

- Abbott

- C.B. Fleet

- Purdue Pharma

- Teva Pharmaceutical

- Sanofi

- Boehringer Ingelheim

- Xiuzheng Pharmaceutical Group

- China Resources Sanjiu Medical & Pharmaceutical

- Harbin Pharmaceutical Group

- JZJT

- Tongrentang (TRT)

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

- North America

- Europe

- Asia-Pacific

- South America

- Middle East & Africa

The regional scope of the study is as follows:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Capsule

- Tablet

- Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

The study objectives of this report are:

- To analyze and study the global Gastrointestinal OTC Drugs sales, value, status (2013-2017) and forecast (2018-2025).

- Focuses on the key Gastrointestinal OTC Drugs manufacturers, to study the sales, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Gastrointestinal OTC Drugs are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Gastrointestinal OTC Drugs Manufacturers

Gastrointestinal OTC Drugs Distributors/Traders/Wholesalers

Gastrointestinal OTC Drugs Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Gastrointestinal OTC Drugs market, by end-use.

Detailed analysis and profiles of additional market players.

Global Gastrointestinal OTC Drugs Market Research Report 2018

Table of Contents
Global Gastrointestinal OTC Drugs Market Research Report 2018
1 Gastrointestinal OTC Drugs Market Overview
1.1 Product Overview and Scope of Gastrointestinal OTC Drugs
1.2 Gastrointestinal OTC Drugs Segment by Type (Product Category)
1.2.1 Global Gastrointestinal OTC Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Gastrointestinal OTC Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Others
1.3 Global Gastrointestinal OTC Drugs Segment by Application
1.3.1 Gastrointestinal OTC Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Gastrointestinal OTC Drugs Market by Region (2013-2025)
1.4.1 Global Gastrointestinal OTC Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 Asia-Pacific Status and Prospect (2013-2025)
1.4.5 South America Status and Prospect (2013-2025)
1.4.6 Middle East & Africa Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Gastrointestinal OTC Drugs (2013-2025)
1.5.1 Global Gastrointestinal OTC Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Gastrointestinal OTC Drugs Capacity, Production Status and Outlook (2013-2025)
2 Global Gastrointestinal OTC Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal OTC Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Gastrointestinal OTC Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Gastrointestinal OTC Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Gastrointestinal OTC Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Gastrointestinal OTC Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Gastrointestinal OTC Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Gastrointestinal OTC Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal OTC Drugs Market Concentration Rate
2.5.2 Gastrointestinal OTC Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Gastrointestinal OTC Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Gastrointestinal OTC Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Gastrointestinal OTC Drugs Production and Market Share by Region (2013-2018)
3.3 Global Gastrointestinal OTC Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 Asia-Pacific Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 South America Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Middle East & Africa Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Gastrointestinal OTC Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Gastrointestinal OTC Drugs Consumption by Region (2013-2018)
4.2 North America Gastrointestinal OTC Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Gastrointestinal OTC Drugs Production, Consumption, Export, Import (2013-2018)
4.4 Asia-Pacific Gastrointestinal OTC Drugs Production, Consumption, Export, Import (2013-2018)
4.5 South America Gastrointestinal OTC Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Middle East & Africa Gastrointestinal OTC Drugs Production, Consumption, Export, Import (2013-2018)
5 Global Gastrointestinal OTC Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Gastrointestinal OTC Drugs Production and Market Share by Type (2013-2018)
5.2 Global Gastrointestinal OTC Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Gastrointestinal OTC Drugs Price by Type (2013-2018)
5.4 Global Gastrointestinal OTC Drugs Production Growth by Type (2013-2018)
6 Global Gastrointestinal OTC Drugs Market Analysis by Application
6.1 Global Gastrointestinal OTC Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Gastrointestinal OTC Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Gastrointestinal OTC Drugs Manufacturers Profiles/Analysis
7.1 Bayer
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bayer Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 GlaxoSmithKline
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 GlaxoSmithKline Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Johnson & Johnson
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Pfizer
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Pfizer Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Perrigo
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Perrigo Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Abbott
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Abbott Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 C.B. Fleet
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 C.B. Fleet Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Purdue Pharma
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Purdue Pharma Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Teva Pharmaceutical
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Sanofi
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Sanofi Gastrointestinal OTC Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Boehringer Ingelheim
7.12 Xiuzheng Pharmaceutical Group
7.13 China Resources Sanjiu Medical & Pharmaceutical
7.14 Harbin Pharmaceutical Group
7.15 JZJT
7.16 Tongrentang (TRT)
8 Gastrointestinal OTC Drugs Manufacturing Cost Analysis
8.1 Gastrointestinal OTC Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Gastrointestinal OTC Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Gastrointestinal OTC Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Gastrointestinal OTC Drugs Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Gastrointestinal OTC Drugs Market Forecast (2018-2025)
12.1 Global Gastrointestinal OTC Drugs Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Gastrointestinal OTC Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Gastrointestinal OTC Drugs Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Gastrointestinal OTC Drugs Price and Trend Forecast (2018-2025)
12.2 Global Gastrointestinal OTC Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Gastrointestinal OTC Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Gastrointestinal OTC Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 Asia-Pacific Gastrointestinal OTC Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 South America Gastrointestinal OTC Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Middle East & Africa Gastrointestinal OTC Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Gastrointestinal OTC Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Gastrointestinal OTC Drugs Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Gastrointestinal OTC Drugs
Figure Global Gastrointestinal OTC Drugs Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Gastrointestinal OTC Drugs Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Capsule
Table Major Manufacturers of Capsule
Figure Product Picture of Tablet
Table Major Manufacturers of Tablet
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Gastrointestinal OTC Drugs Consumption (K Pcs) by Applications (2013-2025)
Figure Global Gastrointestinal OTC Drugs Consumption Market Share by Applications in 2017
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure Global Gastrointestinal OTC Drugs Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2013-2025)
Figure North America Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure South America Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East & Africa Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Gastrointestinal OTC Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Gastrointestinal OTC Drugs Capacity, Production (K Pcs) Status and Outlook (2013-2025)
Figure Global Gastrointestinal OTC Drugs Major Players Product Capacity (K Pcs) (2013-2018)
Table Global Gastrointestinal OTC Drugs Capacity (K Pcs) of Key Manufacturers (2013-2018)
Table Global Gastrointestinal OTC Drugs Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Gastrointestinal OTC Drugs Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Gastrointestinal OTC Drugs Capacity (K Pcs) of Key Manufacturers in 2018
Figure Global Gastrointestinal OTC Drugs Major Players Product Production (K Pcs) (2013-2018)
Table Global Gastrointestinal OTC Drugs Production (K Pcs) of Key Manufacturers (2013-2018)
Table Global Gastrointestinal OTC Drugs Production Share by Manufacturers (2013-2018)
Figure 2017 Gastrointestinal OTC Drugs Production Share by Manufacturers
Figure 2017 Gastrointestinal OTC Drugs Production Share by Manufacturers
Figure Global Gastrointestinal OTC Drugs Major Players Product Revenue (Million USD) (2013-2018)
Table Global Gastrointestinal OTC Drugs Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers
Table 2018 Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers
Table Global Market Gastrointestinal OTC Drugs Average Price (USD/Pcs) of Key Manufacturers (2013-2018)
Figure Global Market Gastrointestinal OTC Drugs Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Gastrointestinal OTC Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Gastrointestinal OTC Drugs Product Category
Figure Gastrointestinal OTC Drugs Market Share of Top 3 Manufacturers
Figure Gastrointestinal OTC Drugs Market Share of Top 5 Manufacturers
Table Global Gastrointestinal OTC Drugs Capacity (K Pcs) by Region (2013-2018)
Figure Global Gastrointestinal OTC Drugs Capacity Market Share by Region (2013-2018)
Figure Global Gastrointestinal OTC Drugs Capacity Market Share by Region (2013-2018)
Figure 2017 Global Gastrointestinal OTC Drugs Capacity Market Share by Region
Table Global Gastrointestinal OTC Drugs Production by Region (2013-2018)
Figure Global Gastrointestinal OTC Drugs Production (K Pcs) by Region (2013-2018)
Figure Global Gastrointestinal OTC Drugs Production Market Share by Region (2013-2018)
Figure 2017 Global Gastrointestinal OTC Drugs Production Market Share by Region
Table Global Gastrointestinal OTC Drugs Revenue (Million USD) by Region (2013-2018)
Table Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2013-2018)
Figure Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2013-2018)
Table 2017 Global Gastrointestinal OTC Drugs Revenue Market Share by Region
Figure Global Gastrointestinal OTC Drugs Capacity, Production (K Pcs) and Growth Rate (2013-2018)
Table Global Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table North America Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Europe Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Asia-Pacific Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table South America Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Middle East & Africa Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Global Gastrointestinal OTC Drugs Consumption (K Pcs) Market by Region (2013-2018)
Table Global Gastrointestinal OTC Drugs Consumption Market Share by Region (2013-2018)
Figure Global Gastrointestinal OTC Drugs Consumption Market Share by Region (2013-2018)
Figure 2017 Global Gastrointestinal OTC Drugs Consumption (K Pcs) Market Share by Region
Table North America Gastrointestinal OTC Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Europe Gastrointestinal OTC Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Asia-Pacific Gastrointestinal OTC Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table South America Gastrointestinal OTC Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Middle East & Africa Gastrointestinal OTC Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Global Gastrointestinal OTC Drugs Production (K Pcs) by Type (2013-2018)
Table Global Gastrointestinal OTC Drugs Production Share by Type (2013-2018)
Figure Production Market Share of Gastrointestinal OTC Drugs by Type (2013-2018)
Figure 2017 Production Market Share of Gastrointestinal OTC Drugs by Type
Table Global Gastrointestinal OTC Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Gastrointestinal OTC Drugs Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Gastrointestinal OTC Drugs by Type (2013-2018)
Figure 2017 Revenue Market Share of Gastrointestinal OTC Drugs by Type
Table Global Gastrointestinal OTC Drugs Price (USD/Pcs) by Type (2013-2018)
Figure Global Gastrointestinal OTC Drugs Production Growth by Type (2013-2018)
Table Global Gastrointestinal OTC Drugs Consumption (K Pcs) by Application (2013-2018)
Table Global Gastrointestinal OTC Drugs Consumption Market Share by Application (2013-2018)
Figure Global Gastrointestinal OTC Drugs Consumption Market Share by Applications (2013-2018)
Figure Global Gastrointestinal OTC Drugs Consumption Market Share by Application in 2017
Table Global Gastrointestinal OTC Drugs Consumption Growth Rate by Application (2013-2018)
Figure Global Gastrointestinal OTC Drugs Consumption Growth Rate by Application (2013-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer Gastrointestinal OTC Drugs Production Growth Rate (2013-2018)
Figure Bayer Gastrointestinal OTC Drugs Production Market Share (2013-2018)
Figure Bayer Gastrointestinal OTC Drugs Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Production Growth Rate (2013-2018)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Production Market Share (2013-2018)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Production Growth Rate (2013-2018)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Production Market Share (2013-2018)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Revenue Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Gastrointestinal OTC Drugs Production Growth Rate (2013-2018)
Figure Pfizer Gastrointestinal OTC Drugs Production Market Share (2013-2018)
Figure Pfizer Gastrointestinal OTC Drugs Revenue Market Share (2013-2018)
Table Perrigo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Perrigo Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Perrigo Gastrointestinal OTC Drugs Production Growth Rate (2013-2018)
Figure Perrigo Gastrointestinal OTC Drugs Production Market Share (2013-2018)
Figure Perrigo Gastrointestinal OTC Drugs Revenue Market Share (2013-2018)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Abbott Gastrointestinal OTC Drugs Production Growth Rate (2013-2018)
Figure Abbott Gastrointestinal OTC Drugs Production Market Share (2013-2018)
Figure Abbott Gastrointestinal OTC Drugs Revenue Market Share (2013-2018)
Table C.B. Fleet Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table C.B. Fleet Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure C.B. Fleet Gastrointestinal OTC Drugs Production Growth Rate (2013-2018)
Figure C.B. Fleet Gastrointestinal OTC Drugs Production Market Share (2013-2018)
Figure C.B. Fleet Gastrointestinal OTC Drugs Revenue Market Share (2013-2018)
Table Purdue Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Purdue Pharma Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Purdue Pharma Gastrointestinal OTC Drugs Production Growth Rate (2013-2018)
Figure Purdue Pharma Gastrointestinal OTC Drugs Production Market Share (2013-2018)
Figure Purdue Pharma Gastrointestinal OTC Drugs Revenue Market Share (2013-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Production Growth Rate (2013-2018)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Production Market Share (2013-2018)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Revenue Market Share (2013-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Gastrointestinal OTC Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sanofi Gastrointestinal OTC Drugs Production Growth Rate (2013-2018)
Figure Sanofi Gastrointestinal OTC Drugs Production Market Share (2013-2018)
Figure Sanofi Gastrointestinal OTC Drugs Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal OTC Drugs
Figure Manufacturing Process Analysis of Gastrointestinal OTC Drugs
Figure Gastrointestinal OTC Drugs Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal OTC Drugs Major Manufacturers in 2017
Table Major Buyers of Gastrointestinal OTC Drugs
Table Distributors/Traders List
Figure Global Gastrointestinal OTC Drugs Capacity, Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Gastrointestinal OTC Drugs Price (Million USD) and Trend Forecast (2018-2025)
Table Global Gastrointestinal OTC Drugs Production (K Pcs) Forecast by Region (2018-2025)
Figure Global Gastrointestinal OTC Drugs Production Market Share Forecast by Region (2018-2025)
Table Global Gastrointestinal OTC Drugs Consumption (K Pcs) Forecast by Region (2018-2025)
Figure Global Gastrointestinal OTC Drugs Consumption Market Share Forecast by Region (2018-2025)
Figure North America Gastrointestinal OTC Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure North America Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Gastrointestinal OTC Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Europe Gastrointestinal OTC Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Gastrointestinal OTC Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Asia-Pacific Gastrointestinal OTC Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Gastrointestinal OTC Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure South America Gastrointestinal OTC Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure South America Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table South America Gastrointestinal OTC Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Middle East & Africa Gastrointestinal OTC Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Middle East & Africa Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Middle East & Africa Gastrointestinal OTC Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Table Global Gastrointestinal OTC Drugs Production (K Pcs) Forecast by Type (2018-2025)
Figure Global Gastrointestinal OTC Drugs Production (K Pcs) Forecast by Type (2018-2025)
Table Global Gastrointestinal OTC Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Gastrointestinal OTC Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Gastrointestinal OTC Drugs Price Forecast by Type (2018-2025)
Table Global Gastrointestinal OTC Drugs Consumption (K Pcs) Forecast by Application (2018-2025)
Figure Global Gastrointestinal OTC Drugs Consumption (K Pcs) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • Global Exocrine Pancreatic Insufficiency Market Size, Status and Forecast 2025
    Published: 23-Jul-2018        Price: US 3300 Onwards        Pages: 96
    This report studies the global Exocrine Pancreatic Insufficiency market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Exocrine Pancreatic Insufficiency market by companies, region, type and end-use industry. Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas. EPI is commonly found in humans affected ......
  • Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 601
    Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2018, provides an overview of the Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipeline landscape. Non-alcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. NASH can get worse and cause scarrin......
  • Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 243
    Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2018, provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) pipeline landscape. Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease. Nonalcoholic fatty li......
  • Global Esomeprazole Market Research Report 2018
    Published: 13-Jul-2018        Price: US 2900 Onwards        Pages: 93
    This report studies the global Esomeprazole market status and forecast, categorizes the global Esomeprazole market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Esomeprazole market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major man......
  • 2018-2023 Global Gastrointestinal Consumption Market Report
    Published: 12-Jul-2018        Price: US 4660 Onwards        Pages: 164
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Gastrointestinal market for 2018-2023. Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders. The global average gross margin of Gast......
  • 2018 Top 5 Gastrointestinal Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 12-Jul-2018        Price: US 4960 Onwards        Pages: 145
    Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders. The global average gross margin of Gastrointestinal is in a slight decreasing trend, and the gross margin is 63% in 2015. Europe region is the largest supplier of Gastrointestinal, with a production revenue marke......
  • Hepatic Encephalopathy - Pipeline Review, H2 2018
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 72
    Hepatic Encephalopathy - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatic Encephalopathy - Pipeline Review, H2 2018, provides an overview of the Hepatic Encephalopathy (Gastrointestinal) pipeline landscape. Hepatic encephalopathy is a worsening of brain function that occurs when the liver is no longer able to remove toxic substances in the blood. Symptoms include disorientation, dro......
  • Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2018
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 35
    Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2018, provides an overview of the Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline landscape. Non-ulcer dyspepsia is a term used to describe signs and symptoms of indigestion that have no obvious cause. Non-ulcer dyspepsia is also called func......
  • Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2018
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 91
    Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atypical Hemolytic Uremic Syndrome - Pipeline Review, H2 2018, provides an overview of the Atypical Hemolytic Uremic Syndrome (Gastrointestinal) pipeline landscape. Atypical hemolytic uremic syndrome is a disease that primarily affects kidney function. T......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs